Choledochal cysts, are rare congenital dilations (enlargements) of the bile ducts, a network of  long tube-like structures that carry bile from the liver to small intestine for digestion.

Bilary System  401 X 263

Biliary System

Choledochal cysts are classified into 5 types, based on site of the cyst or dilatation.

  • Type I: Most common variety (80-90%) involving saccular or fusiform dilatation of a portion or entire common bile duct (CBD) with normal intrahepatic duct.
  • Type II: Isolated diverticulum protruding from the CBD.
  • Type III or Choledochocele: Arise from dilatation of duodenal portion of CBD or where pancreatic duct meets.
  • Type IVa: Characterized by multiple dilatations of the intrahepatic and extrahepatic biliary tree.
  • Type IVb: Multiple dilatations involving only the extrahepatic bile ducts.
  • Type V or Caroli's disease: Cystic dilatation of intra hepatic biliary ducts

Choledochal Cysts

Epidemiology

Although choledochal cysts are present at birth, they are increasingly diagnosed in adults and now comprise 20% of all new cases. Choledochal cysts are inflammatory in nature. Left untreated, this frequently lead to recurrent cholangitis (inflammation and infection in the bile ducts) or pancreatitis (inflammation of the pancreas). 

Surgical Treatment

Bile duct surgery with total cyst removal is the definitive treatment for choledochal cysts. In earlier decades, an operation known as cystenterostomy was performed that only drained the cyst and the bilary reconstruction left the cyst behind.  That surgery proved ineffective, leaving many patients with recurrent cholangitis and chronic inflammation in the remaining cyst, and the substantial risk of malignant transformation into cholangiocarcinoma (bile duct cancer).

Today, the surgical treatment choledochal cysts cyst is completed excision followed by reconstruction of the biliary tree with hepaticojejunostomy in a Roux-en-Y fashion has been widely accepted as the procedure of choice. Future complications include cholangitis and a 2% risk of malignancy, which may develop in any part of the biliary tree.